News
TipRanks on MSN3d
Replimune receives complete response letter from FDA for RP1 BLAReplimune (REPL) announced that the U.S. Food and Drug Administration, FDA, has issued a Complete Response Letter, CRL, regarding the Biologics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback